A cell adhesion peptide from foot-and-mouth disease virus can direct cell targeted delivery of a functional enzyme

Biotechnology and Bioengineering

Volumn 59, Issue 3, 1998, Pages 294-301

  Villaverde, Antonio ^a   Feliu, Jordi X ^a   Arís, Anna ^a   Harbottle, Richard P ^b   Benito, Antoni ^a,c   Coutelle, Charles ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b ST MARY S HOSPITAL   (United Kingdom)

^c CNRS   (France)

Author keywords

galactosidase; Cell binding; FMDV; Integrins; Internalization; RGD

Indexed keywords

AMINO ACIDS; CELLS; ENZYMES; GENES; VIRUSES;

ARGININE-GLYCINE-ASPARTIC ACID; CELL ADHESION PEPTIDE; CELL BINDING; FOOT-AND-MOUTH DISEASE VIRUS; GALACTOSIDASE; INTERNALIZATION; LIGAND;

BIOTECHNOLOGY;

ARGINYLGLYCYLASPARTIC ACID; BETA GALACTOSIDASE; CELL SURFACE RECEPTOR; CHIMERIC PROTEIN; INTEGRIN; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CONTROLLED STUDY; ESCHERICHIA COLI; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE TARGETING; HELA CELL; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NONHUMAN; PROTEIN PURIFICATION; VIRION; VIRUS CELL INTERACTION;

AMINO ACID SEQUENCE; APHTHOVIRUS; BETA-GALACTOSIDASE; BIOREACTORS; CAPSID; CAPSID PROTEINS; CELL ADHESION; ESCHERICHIA COLI; GENETIC ENGINEERING; GENETIC VECTORS; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS;

EID: 0032486745     PISSN: 00063592     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0290(19980805)59:3<294::AID-BIT5>3.0.CO;2-6     Document Type: Article

References (40)

1. Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D., Brown, F. 1989. The three dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337: 709-716.
2. Bekkers, A. C., Slothoom, A. J., van Willigen, G., Akkerman, J. W., Verheij, H. M. 1996. Targeting of porcine pancreatic phospholipase A2 to human platelets. Introduction of an RGD sequence and acyl-group by chemical modification. Eur. J. Biochem. 238: 70-76.
3. + strains. J. Biotechnol. 29: 299-306.
4. Benito, A., Villaverde, A. 1994. Insertion of a 27 amino acid viral peptide in different zones of E. coli β-galactosidase: Effects on enzyme activity. FEMS Microbiol. Lett. 123: 107-112.
5. Benito, A., Mateu, M. G., Villaverde, A. 1995. Improved mimicry of a foot-and-mouth disease virus antigenic site by a viral peptide displayed on β-galactosidase surface. Bio/Technology 13: 801-804.
6. Benito, A., Feliu, J. X., Villaverde, A. 1996. β-Galactosidase enzymatic activity as a molecular probe to detect specific antibodies. J. Biol. Chem. 271: 21251-21256.
7. 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69: 2664-2666.
8. Brasaemle, D. L., Attie, A.D. 1988. Microelisa reader quantitation of fixed, stained, solubilized cells in microtiter dishes. BioTechniques 6: 418-419.
9. Capucci, L., Brocchi, E., De Simone, F., Panina, G. F. 1984. Characterization of monodonal antibodies produced against foot-and-mouth disease viruses pp. 32-39. In: Brescia (ed.), Report of a session of the research group of the standing technical committee of the European Commission for the Control of Foot-and-Mouth Disease. Food and Agriculture Organization of the United Nations.
10. Chambers, M., Dougan, G., Newman, J., Brown, F., Crowther, J., Mould. A. P., Humphries, M. J., Francis, M. J., Clarke, B., Brown, A. L., Rowlands, D. 1996. Chimeric hepatitis B virus core particles as probes for studying peptide-integrin interactions. J. Virol, 70: 4045-4052.
11. Feliu, J. X., Villaverde, A. 1994. An optimized ultrasonication protocol for bacterial cell disruption and recovery of β-galactosidase proteins. Biotech. Tech. 8: 509-514.
12. Hanïson S. C. 1989. Finding the receptors. Nature 338: 205-206.
13. 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway. J. Virol. 69: 5951-5958.
14. Hart, S. L., Knight, A. M., Harbottle, R. P., Mistry, A., Hunger, H. -D., Cutler, D. F., Williamson, R., Coutelle, C. 1994. Cell binding and intemalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J. Biol. Chem. 269: 12468-12474.
15. Jackson, T., Ellard F. M., Ghazaleh, R. A., Brookes, S. M., Blakemore, W. E., Corteyn, A. H., Stuart, D. I., Newman, J. W. I., King, A. M. Q. 1996. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 70: 5282-5287.
16. 3 in vitro. J. Virol. 71: 8357-8361.
17. Jacobson, R. H., Zhang, X-J., DuBose. R. F., Matthews, B.W. 1994. Three-dimensional structure of β-galactosidase from E. coli. Nature 369: 761-766.
18. Kotin, R. M. 1994. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5: 793-801.
19. Lea, S., Hernández, J., Blakemore, W., Brocchi, E., Curry, S., Domingo, E., Fry, E., Abu-Ghazaleh, R., King, A., Newman, J., Stuart, D., Mateu, M. G. 1994. The structure and antigenicity of a type C foot-andmouth disease virus. Structure 2: 123-139.
20. 1K affect virus attachment to target cells. J. Virol. 71: 1046-1051.
21. Martínez, M. A., Verdaguer. N., Mateu, M. G., Domingo, E. 1997. Evolution subverting essentiality; Dispensability of the cell attachment Arg-Gly-Asp motif in multiply passaged foot-and-mouth disease virus. Proc. Natl. Acad. Sci. USA 94: 6798-4802.
22. Mateu, M. G., Martínez, M. A., Capucci, L., Andreu, D., Giralt, E., Brocchi, E., Domingo, E. 1990. A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J. Gen. Virol. 71: 629-637.
23. Mateu, M. G., Veleron, M. L., Andreu, D., Domingo, E. 1996. Systematic replacement of amino acid residues within an Arg-Gly-Asp-containing loop of foot-and-mouth disease virus and effect on cell recognition. J. Biol. Chem. 271: 12814-12819.
24. McKenna, T. S. C., Lubroth, J., Rieder, E., Baxt, B., Mason, P. W. 1995. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virology 69: 5787-5790.
25. McLachlin, J. R., Cometta, K., Eglitis, M. A., Anderson, W. F. I990. Retroviral-mediated gene transfer. Prog. Nucleic Acid. Res. Mol. Biol. 38: 91-135.
26. Miller, J. H. 1972, Experiments in molecular genetics, pp. 352-355. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
27. Nolan, G. P. 1997. Harnessing viral devices as pharmaceuticals: Fighting HIV-I's fire with fire. Cell 90: 821-824.
28. Pierschbacher, M. D., Ruoslahti, E. 1987. Influence of stereochemistry of the sequence Arg-Gly-Asp-Xxx on binding specificity in cell adhesion. J. Biol. Chem. 262: 17294-17298.
29. Rosenfeld, M. A., Yoshimura, K., Trapnell, B. C., Yoneyama, K., Rosenthal, E. R., Dalemans, W., Fukayama, M., Bargon, J.t Stier, L. E., Stratford-Perricaudet, M., Guggino, W. B., Pavirani, A., Lecoq, J.-P., Crystal, R. G. 1992. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68: 143-155.
30. Ruoslahti, E., Pierschbacher, M. D. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238: 491-491.
31. Sa-Carvalho, D., Rieder, E., Baxt, B., Rodarte, R., Tanuri. A., Mason, P. W. 1997. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 71: 5115-5123.
32. Sobrino, F., Dávila, M., Ortín, J., Domingo, E. 1983. Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology 128: 310-318.
33. Studier, F. W., Moffat, B. A. 1986. Use of the bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. Ullmann, A. 1992. Complementation in β-galactosidase: From protein structure to genetic engineering. BioEssays 14: 201-205.
34. Ullmann, A. 1984. One-step purification of hybrid proteins which have β-galactosidase activity. Gene 29: 27-31.
35. Vidal, M. Cairó, J., Mateu, M. G., Villaverde, A. 1991. Molecular cloning and expression of the VP1 gene of foot-and-mouth disease virus C1 in E. coli: Effects on bacterial cell viability. Appl. Microbiol. Biotechnol. 35: 788-792.
36. Villaverde, A., Feliu, J. X., Harbottle, R. P., Benito, A., Coutelle, C. 1996. A recombinant, arginine-glycine- aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors. Gene 180: 101-106.
37. Wickham, T. J., Mathias, P., Nemerow, G. R. 1993. Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment. Cell 73: 309-319.
38. Wickham, T. J., Carrion, M. E., Kovesdi, I. 1995. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther. 2: 750-756.
39. Wickham, T. J., Tzeng, E., Shears, L. L. 2nd, Roelvink P. W., Li, Y., Lee, G. M., Brough D. E., Lizonova A., Kovesdi, I. 1997. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J. Virol. 71: 8221-8229.
40. Yang, Y., Li, Q., Ertl, H. C. J., Wilson, J. M. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69: 2004-2015.